This symposium examines the latest advances in anti-infectives drug discovery from a medicinal chemist’s perspective, focusing on the challenges associated with anti-infectives development and the latest strategies for tackling infection.
Selected Speakers
- Clive Mason, Life Arc, United Kingdom
- Ester Morreale, The Francis Crick Institute, United Kingdom
- Pam Brown, Centauri Therapeutics, United Kingdom
- Agata Laydon, Google Deep Mind, United Kingdom
- Oleg Kovalevskiy, Google Deep Mind, United Kingdom
- Fredrik Almqvist, Quretech Bio, Sweden
- Olga Genilloud, Fundacion Medina, Grenada, Spain
- Ali Tavassoli, University of Southampton, United Kingdom
- Ed Griffen, MedChemica, United Kingdom
- Dafydd Owen, Pfizer, United States
- Rob Howes, Charles River Laboratories, United Kingdom
- Patrick Chaltin, Centre for Drug Discovery and Design, KU Leuven, Belgium
- Johan Neyts, KU Leuven, Belgium
- Patrizzio Mattei, Roche, Switzerland
- Ian Cooper, Infex Therapeutics, United Kingdom
- Eachan Johnson, The Francis Crick Institute, United Kingdom
- Ed Tate, Imperial College London and The Francis Crick Institute, United Kingdom
